I am an expert in medicinal chemistry and currently lead compound management and biobank capabilities to support all stages of drug research and development with small molecules and human biological samples. I also lead the strategic development of Machine Learning for drug design and synthesis at AstraZeneca.
Before joining AstraZeneca in 2001, I undertook a PhD and post doc in organic chemistry. Over the past 18 years, I have developed a proven track record of delivering global scientific services and capabilities with transformational change in performance, operations and external scientific reputation, through collaboration on multidisciplinary research and project teams.
During my time at AstraZeneca, I have become an accomplished leader of people with a passion for innovation and developing a culture of improvement and adaptability.
I’m passionate about the development of automated technology innovation for compound design, synthesis and distribution. I believe advances in robotics and artificial intelligence offer genuine promise of improvement in drug discovery productivity.
Key Achievements
2018
2017
2016
Featured publications
Advancing automation in Compound Management: a novel industrial process underpinning drug discovery.
Green et al. Drug Discovery Today, 2020. Publication link: http://www.sciencedirect.com/science/article/abs/pii/S1359644620303895?via%3Dihub
Why a special issue on acoustic liquid handling.
Journal of the Association for Laboratory Automation. 2016; 21(1):1-3. Olechno J, Green C, Rasmussen L. Publication link: http://journals.sagepub.com/doi/full/10.1177/2211068215619712
Consolidating a distributed compound management capability into a single installation: The application of Overall Equipment Effectiveness to determine capacity utilization.
Journal of the Association for Laboratory Automation. 2015; 21(6):811-816. Green C, Taylor T. Publication link: http://journals.sagepub.com/doi/abs/10.1177/2211068215623048